221 related articles for article (PubMed ID: 31488793)
1. Clozapine: promising treatment for suicidality in bipolar disorder.
Wilkowska A; Wiglusz MS; Cubała WJ
Psychiatr Danub; 2019 Sep; 31(Suppl 3):574-578. PubMed ID: 31488793
[TBL] [Abstract][Full Text] [Related]
2. Prevention of suicide by clozapine in mental disorders: systematic review.
Masdrakis VG; Baldwin DS
Eur Neuropsychopharmacol; 2023 Apr; 69():4-23. PubMed ID: 36640481
[TBL] [Abstract][Full Text] [Related]
3. Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports.
Wilkowska A; Wiglusz MS; Cubała WJ
Front Psychiatry; 2019; 10():520. PubMed ID: 31379632
[TBL] [Abstract][Full Text] [Related]
4. Clozapine associated with decreased suicidality in bipolar disorder: a case report.
Vangala VR; Brown ES; Suppes T
Bipolar Disord; 1999 Dec; 1(2):123-4. PubMed ID: 11252659
[No Abstract] [Full Text] [Related]
5. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.
Wasserman D; Rihmer Z; Rujescu D; Sarchiapone M; Sokolowski M; Titelman D; Zalsman G; Zemishlany Z; Carli V;
Eur Psychiatry; 2012 Feb; 27(2):129-41. PubMed ID: 22137775
[TBL] [Abstract][Full Text] [Related]
6. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Meltzer HY; Alphs L; Green AI; Altamura AC; Anand R; Bertoldi A; Bourgeois M; Chouinard G; Islam MZ; Kane J; Krishnan R; Lindenmayer JP; Potkin S;
Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment and crisis intervention for the suicidal bipolar disorder patient.
Saunders KE; Hawton K
Bipolar Disord; 2013 Aug; 15(5):575-83. PubMed ID: 23565916
[TBL] [Abstract][Full Text] [Related]
8. To treat suicidality and impulsivity in bipolar disorders, inclusive, effective and evidence-based psychological interventions should be developed.
Ghassemi AE
Evid Based Nurs; 2024 Jun; 27(3):110. PubMed ID: 37949634
[No Abstract] [Full Text] [Related]
9. Precision medicine for suicidality: from universality to subtypes and personalization.
Niculescu AB; Le-Niculescu H; Levey DF; Phalen PL; Dainton HL; Roseberry K; Niculescu EM; Niezer JO; Williams A; Graham DL; Jones TJ; Venugopal V; Ballew A; Yard M; Gelbart T; Kurian SM; Shekhar A; Schork NJ; Sandusky GE; Salomon DR
Mol Psychiatry; 2017 Sep; 22(9):1250-1273. PubMed ID: 28809398
[TBL] [Abstract][Full Text] [Related]
10. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
Meltzer HY; Okayli G
Am J Psychiatry; 1995 Feb; 152(2):183-90. PubMed ID: 7840350
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder and suicide: research synthesis and clinical translation.
McIntyre RS; Muzina DJ; Kemp DE; Blank D; Woldeyohannes HO; Lofchy J; Soczynska JK; Banik S; Konarski JZ
Curr Psychiatry Rep; 2008 Feb; 10(1):66-72. PubMed ID: 18269897
[TBL] [Abstract][Full Text] [Related]
12. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
[TBL] [Abstract][Full Text] [Related]
13. [Bipolar depression and suicidal behavior].
Guillaume S; Courtet P; Samalin L
Encephale; 2011 Dec; 37 Suppl 3():S169-72. PubMed ID: 22212869
[TBL] [Abstract][Full Text] [Related]
14. Effects on suicidal risk: Comparison of clozapine to other newer medicines indicated to treat schizophrenia or bipolar disorder.
Forte A; Pompili M; Imbastaro B; De Luca GP; Mastrangelo M; Montalbani B; Baldessarini RJ
J Psychopharmacol; 2021 Sep; 35(9):1074-1080. PubMed ID: 34291676
[TBL] [Abstract][Full Text] [Related]
15. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
Wagstaff A; Perry C
CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398
[TBL] [Abstract][Full Text] [Related]
16. Suicidal behaviour in bipolar disorder: risk and prevention.
Tondo L; Isacsson G; Baldessarini R
CNS Drugs; 2003; 17(7):491-511. PubMed ID: 12751919
[TBL] [Abstract][Full Text] [Related]
17. Newer prophylactic agents for bipolar disorder and their influence on suicidality.
Born C; Dittmann S; Post RM; Grunze H
Arch Suicide Res; 2005; 9(3):301-6. PubMed ID: 16020172
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():41-5. PubMed ID: 9766619
[TBL] [Abstract][Full Text] [Related]
19. Bipolar disorders.
McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
[TBL] [Abstract][Full Text] [Related]
20. Qualitative investigation of relatives' and service users' experience of mental healthcare for suicidal behaviour in bipolar disorder.
Clements C; Kapur N; Jones SH; Morriss R; Peters S
BMJ Open; 2019 Nov; 9(11):e030335. PubMed ID: 31719074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
